PH30338A - Pharmaceutical depot compositions containing hirudin - Google Patents

Pharmaceutical depot compositions containing hirudin

Info

Publication number
PH30338A
PH30338A PH47746A PH47746A PH30338A PH 30338 A PH30338 A PH 30338A PH 47746 A PH47746 A PH 47746A PH 47746 A PH47746 A PH 47746A PH 30338 A PH30338 A PH 30338A
Authority
PH
Philippines
Prior art keywords
compositions containing
depot compositions
pharmaceutical depot
containing hirudin
hirudin
Prior art date
Application number
PH47746A
Other languages
English (en)
Inventor
Arvinte Tudor
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PH30338A publication Critical patent/PH30338A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • A61K38/58Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
PH47746A 1993-02-18 1994-02-10 Pharmaceutical depot compositions containing hirudin PH30338A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939303275A GB9303275D0 (en) 1993-02-18 1993-02-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PH30338A true PH30338A (en) 1997-04-02

Family

ID=10730651

Family Applications (1)

Application Number Title Priority Date Filing Date
PH47746A PH30338A (en) 1993-02-18 1994-02-10 Pharmaceutical depot compositions containing hirudin

Country Status (21)

Country Link
US (1) US5472938A (de)
EP (1) EP0624375B1 (de)
JP (1) JP3649343B2 (de)
CN (1) CN1108137A (de)
AT (1) ATE216586T1 (de)
AU (1) AU675471B2 (de)
CA (1) CA2115815A1 (de)
DE (1) DE69430458T2 (de)
DK (1) DK0624375T3 (de)
ES (1) ES2176222T3 (de)
FI (1) FI940726A (de)
GB (1) GB9303275D0 (de)
HU (1) HUT66079A (de)
IL (1) IL108610A (de)
MX (1) MX9401244A (de)
NO (1) NO940551D0 (de)
NZ (1) NZ250895A (de)
PH (1) PH30338A (de)
PT (1) PT624375E (de)
TW (1) TW315303B (de)
ZA (1) ZA941087B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401448D0 (en) * 1994-01-26 1994-03-23 Ciba Geigy Ag Stable dry powders
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
KR20000070338A (ko) * 1997-01-20 2000-11-25 나가시마 카쭈시게, 노미야마 아키히코 펩티드의 안정화 방법 및 당해 방법을 이용한 펩티드 함유 동결건조 의약조성물
NO20013182L (no) 2000-06-26 2001-12-27 Nokian Tyres Plc System og fremgangsmåte for konvertering og overföring av driftsdata for dekk
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2487600A (en) * 1945-10-09 1949-11-08 Sharp & Dohme Inc Aqueous thixotropic gel composition
US3027229A (en) * 1957-12-02 1962-03-27 Diamond Lab Method of preparing hydrated calcium phosphate gels
US2987600A (en) * 1959-03-11 1961-06-06 Corning Glass Works Capacitor edge sealing
ZA883443B (en) * 1987-05-21 1988-11-16 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5204323B1 (en) * 1988-10-06 1995-07-18 Ciba Geigy Corp Hirudin antidotal compositions and methods
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release

Also Published As

Publication number Publication date
AU675471B2 (en) 1997-02-06
NO940551D0 (no) 1994-02-17
NO940551L (de) 1994-08-19
EP0624375A3 (de) 1995-07-19
MX9401244A (es) 1994-08-31
AU5508394A (en) 1994-08-25
HUT66079A (en) 1994-09-28
ATE216586T1 (de) 2002-05-15
ES2176222T3 (es) 2002-12-01
DK0624375T3 (da) 2002-07-29
CA2115815A1 (en) 1994-08-19
FI940726A0 (fi) 1994-02-16
GB9303275D0 (en) 1993-04-07
JP3649343B2 (ja) 2005-05-18
HU9400458D0 (en) 1994-05-30
DE69430458T2 (de) 2002-11-21
TW315303B (de) 1997-09-11
CN1108137A (zh) 1995-09-13
ZA941087B (en) 1994-08-18
EP0624375A2 (de) 1994-11-17
FI940726A (fi) 1994-08-19
IL108610A0 (en) 1994-08-26
EP0624375B1 (de) 2002-04-24
IL108610A (en) 1998-03-10
PT624375E (pt) 2002-08-30
US5472938A (en) 1995-12-05
JPH06256214A (ja) 1994-09-13
NZ250895A (en) 1994-06-27
DE69430458D1 (de) 2002-05-29

Similar Documents

Publication Publication Date Title
CA2336845A1 (en) Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
NZ229284A (en) Antimicrobial composition for generating chlorine dioxide
ES8600051A1 (es) Procedimiento de obtencion de composiciones farmaceuticas a base de derivados de acido glicirretinico.
PL312658A1 (en) Highly concentrated solid mepiquate chloride and chloromequate chloride
IL108610A0 (en) Pharmaceutical compositions containing hirudin
CA2049698A1 (en) Dihydrogen orthophosphate deicing composition
EP0628613A3 (de) Wässrige Beschichtungsmittelzusammensetzung.
IL112389A (en) Freeze dried powder pharmaceutical compositions comprising hirudin
EP0212837A3 (de) Desodorierungsmittel
CY2246B1 (en) Pharmaceutical compositions comprising calcitonin
IL77188A (en) Pharmaceutical compositions containing hpa23 for the treatment of acquired immune deficiency syndrome and analogous syndromes
AU5342090A (en) Stabilized urea based fertilizers for foliar application
GR3030026T3 (en) Stabilised pharmaceutical compositions containing dobutamine
MY113686A (en) Fungicide mixtures
ZA965687B (en) Inhibited pickling acids containing chloride and zinc ions.
CA2054222A1 (en) Corrosion inhibitor for use in coating formulations comprising synergistic combinations of a calcium borate and an amino carboxylate